Position in YARW
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$209
+$6 QoQ
Shares Held
350
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in YARW Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Centerpoint Advisors, LLC holds $78,047 across 7 Biotechnology names. YARW ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
87 | $38,848 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
545 | $35,223 | |
| 3 | PHVS |
Pharvaris N.V.
|
100 | $2,825 | |
| 4 | GERN |
Geron Corp
|
300 | $447 | |
| 5 | NMRA |
Neumora Therapeutics, Inc.
|
220 | $429 | |
| 6 | YARW |
Yarrow Bioscience, Inc.
This page
|
350 | $209 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
5 | $66 |
All Filings in YARW
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $209 | 350 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $203 | 350 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $117 | 350 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $577 | 350 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $553 | 350 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,172 | 350 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $658 | 350 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $689 | 350 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||